{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "D",
          "alt": "A",
          "position": "149"
        },
        "variant_string_id": "DJ-1 D149A"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "DJ-1 is a gene product responsible for a subset of familial Parkinson’s disease (PD). The mechanisms by which mutations in DJ-1 alter its function and account for PD-related pathology remained largely unknown.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to the function of DJ-1 and its alteration by mutations leading to PD pathology."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study demonstrates that DJ-1 is processed by caspase-6 and that the caspase-6-derived C-terminal fragment of DJ-1 accounts for associated p53-dependent cell death. It also shows that the D149A mutation renders DJ-1 resistant to caspase-6 proteolysis and abolishes its protective phenotype.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis/mechanism by assessing the effects of DJ-1 mutations on caspase-6 processing and p53-dependent cell death.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of site-directed mutagenesis to create DJ-1 variants, and subsequent analysis of these variants' susceptibility to caspase-6 proteolysis and their effects on cell death, which are appropriate and valid assays for evaluating the functional impact of the DJ-1 D149A mutation."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "Unlike the D149A mutation, the L166P mutation that prevents DJ-1 dimerization does not impair its proteolysis by caspase-6 although it also abolishes DJ-1 antiapoptotic function. The D149A mutation fully blocks DJ-1 cleavage by recombinant caspase-6.",
          "judgment": "Yes",
          "reasoning": "The paper provides evidence that the D149A mutation specifically affects DJ-1's processing by caspase-6, leading to a loss of function and increased susceptibility to cell death, which is consistent with a pathogenic effect."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The D149A mutation in DJ-1 was found to block caspase-6-mediated cleavage, leading to a loss of the protective C-terminal fragment and resulting in increased susceptibility to cell death. This functional evidence strongly supports a pathogenic role for the DJ-1 D149A variant in Parkinson’s disease."
    },
    {
      "variant_id": {
        "Gene": "DJ-1",
        "Protein_Change": {
          "ref": "L",
          "alt": "P",
          "position": "166"
        },
        "variant_string_id": "DJ-1 L166P"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "DJ-1 is a gene product responsible for a subset of familial Parkinson’s disease (PD). The mechanisms by which mutations in DJ-1 alter its function and account for PD-related pathology remained largely unknown.",
          "judgment": "Yes",
          "reasoning": "The paper clearly defines the disease mechanism as related to the function of DJ-1 and its alteration by mutations leading to PD pathology."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "The study demonstrates that DJ-1 is processed by caspase-6 and that the caspase-6-derived C-terminal fragment of DJ-1 accounts for associated p53-dependent cell death. It also shows that the L166P mutation prevents DJ-1 dimerization and abolishes its protective phenotype.",
          "judgment": "Yes",
          "reasoning": "The assays used effectively model the disease pathogenesis/mechanism by assessing the effects of DJ-1 mutations on caspase-6 processing and p53-dependent cell death.",
          "next_step_or_outcome": "Proceed to Step 3"
        },
        {
          "step_name": "Step 3: Evaluate validity of specific instances of assays",
          "judgment": "Yes",
          "reasoning": "The paper describes the use of site-directed mutagenesis to create DJ-1 variants, and subsequent analysis of these variants' effects on cell death, which are appropriate and valid assays for evaluating the functional impact of the DJ-1 L166P mutation."
        },
        {
          "step_name": "Step 4: Apply evidence to individual variant interpretation",
          "extracted_paper_info": "The L166P mutation that prevents DJ-1 dimerization does not impair its proteolysis by caspase-6 although it also abolishes DJ-1 antiapoptotic function.",
          "judgment": "Yes",
          "reasoning": "The paper provides evidence that the L166P mutation affects DJ-1 stability and function, leading to a loss of the protective phenotype and increased susceptibility to cell death, which is consistent with a pathogenic effect."
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The L166P mutation in DJ-1 leads to protein destabilization and a loss of the protective antiapoptotic function, resulting in increased susceptibility to cell death. This functional evidence strongly supports a pathogenic role for the DJ-1 L166P variant in Parkinson’s disease."
    }
  ]
}